Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Dass

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Die Pharmazie|February 3, 2011
Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapyS Hallaj-Nezhadi, F Lotfipour, C R Dass
Anticancer Research|August 15, 2002
Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotidesT L Walker, C R Dass, M A Burton
British Journal of Cancer|October 8, 2011
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma modelM L Broadhead, C R Dass, P F M Choong
Peptides|October 13, 2009
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug deliveryMei Lin Tan, P F M Choong, C R Dass
ANZ Journal of Surgery|July 2, 2009
Development of chondrosarcoma animal models for assessment of adjuvant therapyJ C M Clark, C R Dass, P F M Choong
Journal of Dental Research|September 25, 2007
Angiogenesis inhibitors and the need for anti-angiogenic therapeuticsC R Dass, T M N Tran, P F M Choong
Expert Opinion on Emerging Drugs|December 3, 2008
Current and future treatments of bone metastasesJ C M Clark, C R Dass, Peter F M Choong
Drug Delivery|November 20, 2015
Tumor Gene Targeting Using Microspheres: Cell Culture and in vivo StudiesC R Dass, E E Decruz, T L Walker, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
The basis for somatic gene therapy of cancerE E DeCruz, T L Walker, C R Dass, et al.
Drug Delivery|July 15, 2000
A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor modelC R Dass, T L Walker, W H Kalle, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Die Pharmazie|February 3, 2011
Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapyS Hallaj-Nezhadi, F Lotfipour, C R Dass
Anticancer Research|August 15, 2002
Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotidesT L Walker, C R Dass, M A Burton
British Journal of Cancer|October 8, 2011
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma modelM L Broadhead, C R Dass, P F M Choong
Peptides|October 13, 2009
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug deliveryMei Lin Tan, P F M Choong, C R Dass
ANZ Journal of Surgery|July 2, 2009
Development of chondrosarcoma animal models for assessment of adjuvant therapyJ C M Clark, C R Dass, P F M Choong
Journal of Dental Research|September 25, 2007
Angiogenesis inhibitors and the need for anti-angiogenic therapeuticsC R Dass, T M N Tran, P F M Choong
Expert Opinion on Emerging Drugs|December 3, 2008
Current and future treatments of bone metastasesJ C M Clark, C R Dass, Peter F M Choong
Drug Delivery|November 20, 2015
Tumor Gene Targeting Using Microspheres: Cell Culture and in vivo StudiesC R Dass, E E Decruz, T L Walker, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
The basis for somatic gene therapy of cancerE E DeCruz, T L Walker, C R Dass, et al.
Drug Delivery|July 15, 2000
A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor modelC R Dass, T L Walker, W H Kalle, et al.
Pageof 3